维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Pollyea DA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Oncagenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML 显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
2	A dose escalation study of ibrutinib with lenalidomide for relapsed and refractory chronic lymphocytic leukemia/small lymphocytic lymphoma显示文摘	Pollyea DA Coutre S	2014	Blood2014，124，：	1
3	Safety, efficacy and biological predictors of response to sequential Azacitidine and Lenalidomide for elderly patients with acute myeloid leukemia 显示文摘	Pollyea DA Kohrt HE Gallegos L	2012	Leukemia2012，26，5：	1
4	Acute myeloid leukae miain the elderly:a review 显示文摘	Pollyea DA Kohrt HE Medeiros BC	2011	Br J Haematol2011，152，5：	1
5	Oncogenic CSF3R muta- tions in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N EngI J Med2013，368，19：	1
6	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J pollyea DA	2013	N EnglJ Med2013，368，19：	1
7	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML 显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
8	Targeting acute myeloid leukemia stem cells :a review and prineiples for the development of clinical trials显示文摘	Pollyea DA Gutman JA Gore L	2014	Haematologiea2014，99，8：	1
9	Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia 显示文摘	Pollyea DA Kohrt HE Gallegos L	2012	Leukemia2012，26，5：	1
10	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
11	Targeting acute myeloid leu- kemia stem cells : a review and principles for the development of clinical trials 显示文摘	Pollyea DA Gutman JA Gore L	2014	Haematologica2014，99，8：	1
12	Pona-tinib for the treatment of chronic myeloid leukemia and Philadel-phia chromosome-positive acute lymphoblastic leukemia 显示文摘	NARAYANAN V POLLYEA DA GUTMAN JA	2013	Drugs Today ( Bare)2013，49，4：	1
13	Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia显示文摘	Narayanan V Pollyea DA Gutman JA	2013	Drugs Today (Barc)2013，49，4：	1
14	Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation显示文摘	Pollyea DA Artz AS Stock W	2007	Bone Marrow Transplant2007，40，11：	1
15	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
16	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
17	Oncogenic CSF3R mutations in chronicneutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，：	1
18	Oncogenic CSF3R muta- tions in chronic neutrophilic leukemia and atypical CML 显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1
19	Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials显示文摘	Pollyea DA Gutman JA Gore L	2014	Haematologica2014，99，8：	1
20	Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML显示文摘	Maxson JE Gotlib J Pollyea DA	2013	N Engl J Med2013，368，19：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示